Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
33,917,613
-
Share change
-
+5,726,922
-
Total reported value
-
$769,608,364
-
Price per share
-
$22.69
-
Number of holders
-
94
-
Value change
-
+$131,840,765
-
Number of buys
-
67
-
Number of sells
-
23
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2016
As of 30 Jun 2016,
Theravance Biopharma, Inc. - Common Stock (TBPH) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,917,613 shares.
The largest 10 holders included
Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Cormorant Asset Management, LLC, FIRST MANHATTAN CO, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, and Rock Springs Capital Management LP.
This page lists
94
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.